Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5742-51. doi: 10.1128/AAC.00591-16. Print 2016 Oct. Erratum in: Antimicrob Agents Chemother. 2017 Mar 24;61(4):.

2.

24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00416-17. doi: 10.1128/AAC.00416-17. Print 2017 Nov.

3.

Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.

Avedissian SN, Pais GM, O'Donnell JN, Lodise TP, Liu J, Prozialeck WC, Joshi MD, Lamar PC, Becher L, Gulati A, Hope W, Scheetz MH.

J Antimicrob Chemother. 2019 May 7. pii: dkz167. doi: 10.1093/jac/dkz167. [Epub ahead of print]

PMID:
31065686
4.

Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.

Pais GM, Avedissian SN, O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Lamar PC, Cluff C, Gulati A, Fitzgerald JC, Downes KJ, Zuppa AF, Scheetz MH.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00079-19. doi: 10.1128/AAC.00079-19. Print 2019 Jul.

PMID:
30988153
5.

Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.

Xue W, Xie Y, Wang Q, Xu W, Mou S, Ni Z.

Nephrology (Carlton). 2014 Apr;19(4):186-94. doi: 10.1111/nep.12173.

PMID:
24165570
6.

Monitoring treatment of acute kidney injury with damage biomarkers.

Pianta TJ, Succar L, Davidson T, Buckley NA, Endre ZH.

Toxicol Lett. 2017 Feb 15;268:63-70. doi: 10.1016/j.toxlet.2017.01.001. Epub 2017 Jan 5.

PMID:
28065798
7.

Urinary neutrophil gelatinase-associated lipocalin: a useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients.

Tsuchimoto A, Shinke H, Uesugi M, Kikuchi M, Hashimoto E, Sato T, Ogura Y, Hata K, Fujimoto Y, Kaido T, Kishimoto J, Yanagita M, Matsubara K, Uemoto S, Masuda S.

PLoS One. 2014 Oct 20;9(10):e110527. doi: 10.1371/journal.pone.0110527. eCollection 2014.

8.

Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury.

Won AJ, Kim S, Kim YG, Kim KB, Choi WS, Kacew S, Kim KS, Jung JH, Lee BM, Kim S, Kim HS.

Mol Biosyst. 2016 Jan;12(1):133-44. doi: 10.1039/c5mb00492f.

PMID:
26566257
10.

Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients.

Shinke H, Masuda S, Togashi Y, Ikemi Y, Ozawa A, Sato T, Kim YH, Mishima M, Ichimura T, Bonventre JV, Matsubara K.

Cancer Chemother Pharmacol. 2015 Nov;76(5):989-96. doi: 10.1007/s00280-015-2880-y. Epub 2015 Sep 25.

11.

Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.

Zwiers AJ, de Wildt SN, van Rosmalen J, de Rijke YB, Buijs EA, Tibboel D, Cransberg K.

Crit Care. 2015 Apr 21;19:181. doi: 10.1186/s13054-015-0910-0.

12.

Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.

Hosohata K, Ando H, Fujimura A.

J Pharmacol Exp Ther. 2012 Jun;341(3):656-62. doi: 10.1124/jpet.112.192807. Epub 2012 Mar 7.

PMID:
22399813
13.

Renal function and novel urinary biomarkers in infants with neonatal encephalopathy.

Sweetman DU, Onwuneme C, Watson WR, O'Neill A, Murphy JF, Molloy EJ.

Acta Paediatr. 2016 Nov;105(11):e513-e519. doi: 10.1111/apa.13555.

PMID:
27551944
14.

Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention.

Luo Q, Zhou F, Dong H, Wu L, Chai L, Lan K, Wu M.

Clin Nephrol. 2013 Feb;79(2):85-92. doi: 10.5414/CN106852.

PMID:
23110770
15.

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.

Krawczeski CD, Goldstein SL, Woo JG, Wang Y, Piyaphanee N, Ma Q, Bennett M, Devarajan P.

J Am Coll Cardiol. 2011 Nov 22;58(22):2301-9. doi: 10.1016/j.jacc.2011.08.017.

17.

Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats.

Rouse RL, Zhang J, Stewart SR, Rosenzweig BA, Espandiari P, Sadrieh NK.

Kidney Int. 2011 Jun;79(11):1186-97. doi: 10.1038/ki.2010.463. Epub 2010 Dec 8.

18.

Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.

Parikh CR, Thiessen-Philbrook H, Garg AX, Kadiyala D, Shlipak MG, Koyner JL, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Coca SG; TRIBE-AKI Consortium.

Clin J Am Soc Nephrol. 2013 Jul;8(7):1079-88. doi: 10.2215/CJN.10971012. Epub 2013 Apr 18.

19.

Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery.

Han WK, Wagener G, Zhu Y, Wang S, Lee HT.

Clin J Am Soc Nephrol. 2009 May;4(5):873-82. doi: 10.2215/CJN.04810908. Epub 2009 Apr 30.

20.

Age-related differences in kidney injury biomarkers induced by cisplatin.

Shin YJ, Kim TH, Won AJ, Jung JY, Kwack SJ, Kacew S, Chung KH, Lee BM, Kim HS.

Environ Toxicol Pharmacol. 2014 May;37(3):1028-39. doi: 10.1016/j.etap.2014.03.014. Epub 2014 Mar 26.

PMID:
24751685

Supplemental Content

Support Center